Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.49 USD
Change Today +0.02 / 0.24%
Volume 610.0K
LXRX On Other Exchanges
Symbol
Exchange
LXRX is not on other exchanges.
As of 8:10 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - lexicon pharmaceuticals inc (LXRX)

NameBoard RelationshipsTitleAge
Lonnel Coats 87 RelationshipsChief Executive Officer, President and Director50
Jeffrey L. Wade J.D.No RelationshipsChief Financial Officer and Executive Vice President of Corporate & Administrative Affairs50
John P. Northcott No RelationshipsVice President of Marketing, Commercial Strategy and Operations37
Brian T. Crum No RelationshipsVice President, General Counsel and Secretary--
Pablo Lapuerta M.D.No RelationshipsChief Medical Officer and Executive Vice President52

Board Members - lexicon pharmaceuticals inc (LXRX)

NameBoard RelationshipsPrimary CompanyAge
Raymond Debbane 22 RelationshipsThe Invus Group, LLC60
Lonnel Coats 87 RelationshipsLexicon Pharmaceuticals, Inc.50
Samuel L. Barker Ph.D.53 RelationshipsLexicon Pharmaceuticals, Inc.72
Robert J. Lefkowitz M.D.47 RelationshipsTrevena, Inc.71
Alan Sheffer Nies M.D.8 RelationshipsLexicon Pharmaceuticals, Inc.77

Executive Committees* - lexicon pharmaceuticals inc (LXRX)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeSamuel L. Barker Ph.D. 53 Relationships2 Executives
Compensation CommitteeFrank P. Palantoni B.Sc., M.B.A. 8 Relationships2 Executives
Corporate Governance CommitteeRaymond Debbane 22 Relationships1 Executives
Advisory BoardAlan Sheffer Nies M.D. 8 Relationships1 Executives
View LXRX Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $8.49 USD +0.02

LXRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $50.77 USD -0.29
Boston Scientific Corp $17.25 USD -0.07
CR Bard Inc $193.10 USD -1.45
Johnson & Johnson $99.84 USD +0.11
Medtronic PLC $78.28 USD +0.40
View Industry Companies
 

Industry Analysis

LXRX

Industry Average

Valuation LXRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 36.0x
Price/Book 3.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 18.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.